Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-bromo-7-nitroindazole | nNOS-specific inhibitor, complete inhibition at 0.01 mM | Homo sapiens | |
L-N-methylarginine | NOS inhibitor, complete inhibition at 0.5 mM; NOS inhibitor, complete inhibition at 0.5 mM; NOS inhibitor, complete inhibition at 0.5 mM | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Homo sapiens | P29474 | - |
- |
Homo sapiens | P29475 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
dermal microvascular endothelial cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 L-arginine + 3 NADPH + 3 H+ + 4 O2 | - |
Homo sapiens | 2 citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O | - |
? | |
additional information | NOS has also nitrite reductase activity, the release of free nitric oxide from anoxic nitrite solutions at 0.015 mM is specific to the eNOS isoform and does not occur with the nNOS or iNOS isoforms | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
endothelial NOS | isoform | Homo sapiens |
eNOS | - |
Homo sapiens |
inducible NOS | isoform | Homo sapiens |
iNOS | - |
Homo sapiens |
neuronal NOS | isoform | Homo sapiens |
nNOS | - |
Homo sapiens |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
(6R)-5,6,7,8-tetrahydro-L-biopterin | - |
Homo sapiens | |
Calmodulin | - |
Homo sapiens | |
NADPH | - |
Homo sapiens |